Subcutaneous adipose tissue dopamine D2 receptor is increased in prediabetes and T2D.
Milica VranicFozia AhmedRobin KristófiSusanne HettyDariush MokhtariMaria K SvenssonJan W ErikssonMaria João PereiraPublished in: Endocrine (2023)
The results suggest that protein expression of DRD2 in subcutaneous adipose tissue is up-regulated with hyperglycemia and T2D. Whether DRD2 protein levels contribute to T2D development or occur as a secondary compensatory mechanism needs further investigation. Additionally, dopamine receptor agonists inhibit adipocyte beta-adrenergic stimulation of lipolysis, which might contribute to the beneficial effects in lipid metabolism as observed in patients taking bromocriptine.